Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03803852

Rotation of Hydrophobic Acrylic Lenses - Rayner RA0800C & Alcon Clareon & Hoya Nanex & Hoya Vivinex XY1-EM & RayOne EMV Toric & PODEYE Toric

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
750 (estimated)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
45 Years – 95 Years
Healthy volunteers
Not accepted

Summary

The investigational devices are approved intraocular lenses (IOL) intended to be implanted after phacoemulsification in individuals suffering from age-related cataract with the need of cataract surgery. Within the study, three different IOLs will be investigated and separately evaluated. Cataract surgery with IOL implantation will be performed in subjects who have signed an informed consent form. Postoperative examinations will be postoperative refraction, visual acuity, slitlamp examination, and rotation of the IOL within 1 hour, 1 week, 1 month and 4-7 months. In the Alcon Clareon toric, RayOne EMV toric and PODEYE Toric group, patients receive a toric IOL according to their preoperative astigmatism

Conditions

Interventions

TypeNameDescription
DEVICEIntraocular Lens ImplantationImplantation of an intraocular lens Rayner RayOne or Hoya Nanex or Hoya Vivinex Impressinto the capsular bag using an injector, after removing of the human cristalline lens. Implantation of the Alcon Clareon toric and Rayner RayOne EMV toric IOL and PODEYE Toric IOL on the axis according to the steep meridian of the cornea

Timeline

Start date
2019-01-21
Primary completion
2027-10-01
Completion
2028-01-01
First posted
2019-01-15
Last updated
2025-05-14

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT03803852. Inclusion in this directory is not an endorsement.